StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)

Close on Nov 18, 2026Market cap $7.15MP/E –Yield –

Quoin Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Quoin Pharmaceuticals's enterprise value was -$3.25M on Nov 11, 2026, against $10.96M a year earlier. Over the last 5 years it ranged from -$12.33M to $669.31B, with a median of $1.61M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$3.25M-148.8%
2025Dec 31, 2025$6.66M+3832.6%
2024Dec 31, 2024$169.26K-89.9%
2023Dec 29, 2023$1.68M-100.0%
2022Dec 30, 2022$412.96B+285.7%
2021Dec 31, 2021$107.07B-63.1%
2020Dec 31, 2020$290.44B+67.2%
2019Dec 31, 2019$173.70B-78.8%
2018Dec 31, 2018$820.28B-63.7%
2017Dec 29, 2017$2.26T+227.2%
2016Dec 30, 2016$690.45B–

More Quoin Pharmaceuticals figures

See a number that looks wrong?